Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sugi Holdings CoSGIPF 93 Debt-to-EBITDA is 0.72 as of Feb. 2026, which is 11% below its 10-year median of 0.81. GuruFocus rates SGIPF with a GF Score™ of 93/100 and a GF Value™ of $22.60 (Modestly Overvalued). The stock has 3 warning signs investors should review. Among 478 Healthcare Providers & Services companies, Sugi Holdings Co ranks better than 63.18% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Sugi Holdings Co's Debt-to-EBITDA or its related term are showing as below:
SGIPF'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.02 Med: 0.81 Max: 1.42
Current: 1.39
During the past 13 years, the highest Debt-to-EBITDA Ratio of Sugi Holdings Co was 1.42. The lowest was 0.02. And the median was 0.81.
SGIPF's Debt-to-EBITDA is ranked better than 63.18% of 478
companies
in the Healthcare Providers & Services industry
Industry Median: 2.25
vs SGIPF: 1.39
Sugi Holdings Co (OTCPK:SGIPF) Debt-to-EBITDA Explanation
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Sugi Holdings Co Debt-to-EBITDA Related Terms
Sugi Holdings Co Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Sugi Holdings Co's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sugi Holdings Co Debt-to-EBITDA Competitor Comparison
For the Pharmaceutical Retailers subindustry, Sugi Holdings Co's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sugi Holdings Co Debt-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Sugi Holdings Co's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Sugi Holdings Co's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Feb. 2026) EBITDA data.
Sugi Holdings Co (SGIPF) has a Debt-to-EBITDA of 0.72 as of Feb. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Sugi Holdings Co. This is 11% below median its historical median of 0.81. Over the past decade, Sugi Holdings Co's Debt-to-EBITDA has ranged from 0.02 to 1.42. According to the industry distribution chart, Sugi Holdings Co ranks #176 out of 478 companies in the Healthcare Providers & Services industry, placing it in the top 36.8%.
Is Sugi Holdings Co's Debt-to-EBITDA too high?
Sugi Holdings Co's current Debt-to-EBITDA of 0.72 is 11% below median its 10-year median of 0.81. Over the past 10 years, this metric has ranged from a low of 0.02 to a high of 1.42. The Healthcare Providers & Services industry median Debt-to-EBITDA is 2.25. Sugi Holdings Co's value of 0.72 is 68% below this industry median. Based on the distribution chart, Sugi Holdings Co ranks #176 out of 478 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Sugi Holdings Co has a GF Score™ of 93/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sugi Holdings Co's Debt-to-EBITDA compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Sugi Holdings Co ranks #176 out of 478 companies for Debt-to-EBITDA. This puts Sugi Holdings Co in the upper half of its industry. The industry median Debt-to-EBITDA is 2.25. Sugi Holdings Co's value of 0.72 is 68% below this benchmark. Historically, Sugi Holdings Co's own Debt-to-EBITDA has ranged from 0.02 to 1.42 over the past decade. While the company's 10-year median is 0.81 vs. the industry median of 2.25, Sugi Holdings Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Healthcare Providers & Services company?
The median Debt-to-EBITDA among Healthcare Providers & Services companies is 2.25, based on 478 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sugi Holdings Co's current Debt-to-EBITDA of 0.72 is 68% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Sugi Holdings Co. For the Healthcare Providers & Services industry, the median Debt-to-EBITDA is 2.25 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sugi Holdings Co's current Debt-to-EBITDA is 0.72, which is 11% below median its own 10-year median of 0.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sugi Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Sugi Holdings Co (SGIPF) is currently considered Modestly Overvalued. The stock's GF Value™ is $22.60, compared to a current price of $18.99 — trading 16% below its estimated fair value. The current Debt-to-EBITDA is 0.72, which is 11% below median its 10-year median of 0.81 and 68% below the Healthcare Providers & Services industry median of 2.25. Sugi Holdings Co's overall GF Score™ is 93/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Sugi Holdings Co (SGIPF), the current Debt-to-EBITDA is 0.72 as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sugi Holdings Co (SGIPF) Overvalued in 2026?
Based on GuruFocus' analysis, Sugi Holdings Co stock appears to be undervalued.
The current stock price of $18.99 is trading 16% below its estimated GF Value™ of $22.60.
GuruFocus considers Sugi Holdings Co to be Modestly Overvalued.
Key valuation signals for SGIPF:
Debt-to-EBITDA: 0.72 (11% below median its 10-year median of 0.81)
GF Value™: $22.60 vs. price of $18.99 (16% below fair value)
Industry Position: 68% below the Healthcare Providers & Services median (#176 of 478)
No single metric tells the full story. See the SGIPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sugi Holdings Co Ltd is a Japan-based company engaged in drugstore operations and the pharmaceutical dispensing business. Through its subsidiaries, the company is involved in selling pharmaceuticals, health foods, cosmetics, daily essentials, and prescription drugs. It also operates community-based drugstores that support home healthcare in collaboration with local medical professionals. The company also supports regional healthcare facilities and provides at-home nursing services.
93GF Score
Get the complete analysis for SGIPF
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SGIPF has been successfully added to your 
